MXPA06006387A - Peptidos anfifilicos ramificados, compuestos epitopes relacionados y estructuras auto-ensambladas de los mismos. - Google Patents
Peptidos anfifilicos ramificados, compuestos epitopes relacionados y estructuras auto-ensambladas de los mismos.Info
- Publication number
- MXPA06006387A MXPA06006387A MXPA06006387A MXPA06006387A MXPA06006387A MX PA06006387 A MXPA06006387 A MX PA06006387A MX PA06006387 A MXPA06006387 A MX PA06006387A MX PA06006387 A MXPA06006387 A MX PA06006387A MX PA06006387 A MXPA06006387 A MX PA06006387A
- Authority
- MX
- Mexico
- Prior art keywords
- peptide
- component
- coupled
- compounds
- lysine
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 145
- 150000001875 compounds Chemical class 0.000 title claims abstract description 64
- 125000003277 amino group Chemical group 0.000 claims abstract description 18
- 230000008878 coupling Effects 0.000 claims abstract description 10
- 238000010168 coupling process Methods 0.000 claims abstract description 10
- 238000005859 coupling reaction Methods 0.000 claims abstract description 10
- 235000001014 amino acid Nutrition 0.000 claims description 41
- 150000001413 amino acids Chemical class 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 33
- 230000002209 hydrophobic effect Effects 0.000 claims description 28
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 25
- 239000004472 Lysine Substances 0.000 claims description 25
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims description 15
- 125000000539 amino acid group Chemical group 0.000 claims description 11
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 10
- 230000000975 bioactive effect Effects 0.000 claims description 9
- 239000000693 micelle Substances 0.000 claims description 9
- 238000002823 phage display Methods 0.000 claims description 9
- 239000000523 sample Substances 0.000 claims description 9
- MWOGMBZGFFZBMK-LJZWMIMPSA-N (2s)-2-[[(2s)-2-[[2-[[(2s,3s)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MWOGMBZGFFZBMK-LJZWMIMPSA-N 0.000 claims description 8
- 108010052768 tyrosyl-isoleucyl-glycyl-seryl-arginine Proteins 0.000 claims description 8
- XQQUSYWGKLRJRA-RABCQHRBSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s,3s)-2-amino-3-methylpentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-3-methylbutanoic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O XQQUSYWGKLRJRA-RABCQHRBSA-N 0.000 claims description 7
- 108010088381 isoleucyl-lysyl-valyl-alanyl-valine Proteins 0.000 claims description 7
- 239000004471 Glycine Substances 0.000 claims description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
- 235000004279 alanine Nutrition 0.000 claims description 5
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 4
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 235000018417 cysteine Nutrition 0.000 claims description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 2
- 239000012736 aqueous medium Substances 0.000 claims 2
- 239000012530 fluid Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 9
- 102000004196 processed proteins & peptides Human genes 0.000 description 37
- 239000002121 nanofiber Substances 0.000 description 34
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 17
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 14
- 238000001338 self-assembly Methods 0.000 description 14
- 150000001412 amines Chemical group 0.000 description 13
- 230000027455 binding Effects 0.000 description 13
- 229960002685 biotin Drugs 0.000 description 11
- 235000020958 biotin Nutrition 0.000 description 11
- 239000011616 biotin Substances 0.000 description 11
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 10
- NNRFRJQMBSBXGO-CIUDSAMLSA-N (3s)-3-[[2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O NNRFRJQMBSBXGO-CIUDSAMLSA-N 0.000 description 9
- 230000021164 cell adhesion Effects 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- -1 but not limited to Chemical class 0.000 description 8
- 238000013461 design Methods 0.000 description 8
- 239000003446 ligand Substances 0.000 description 8
- 125000006239 protecting group Chemical group 0.000 description 8
- 101000829980 Homo sapiens Ral guanine nucleotide dissociation stimulator Proteins 0.000 description 7
- 102100023320 Ral guanine nucleotide dissociation stimulator Human genes 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- 108090001008 Avidin Proteins 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000001413 cellular effect Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 108010081400 fluorescein isothiocyante avidin Proteins 0.000 description 6
- 102000005962 receptors Human genes 0.000 description 6
- 108020003175 receptors Proteins 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 238000004132 cross linking Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 238000010647 peptide synthesis reaction Methods 0.000 description 4
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 3
- WDLRUFUQRNWCPK-UHFFFAOYSA-N Tetraxetan Chemical compound OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 WDLRUFUQRNWCPK-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 238000010532 solid phase synthesis reaction Methods 0.000 description 3
- 108010004034 stable plasma protein solution Proteins 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 241000670727 Amida Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000973 chemotherapeutic effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 108010039042 prolyl-histidyl-seryl-arginyl-asparagine Proteins 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- YPTNAIDIXCOZAJ-LHEWISCISA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-6-[[(4-methylphenyl)-diphenylmethyl]amino]hexanoic acid Chemical compound C1=CC(C)=CC=C1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)NCCCC[C@@H](C(O)=O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 YPTNAIDIXCOZAJ-LHEWISCISA-N 0.000 description 1
- BLCJBICVQSYOIF-UHFFFAOYSA-N 2,2-diaminobutanoic acid Chemical compound CCC(N)(N)C(O)=O BLCJBICVQSYOIF-UHFFFAOYSA-N 0.000 description 1
- PECYZEOJVXMISF-UHFFFAOYSA-N 3-aminoalanine Chemical compound [NH3+]CC(N)C([O-])=O PECYZEOJVXMISF-UHFFFAOYSA-N 0.000 description 1
- 239000000592 Artificial Cell Substances 0.000 description 1
- 101100245267 Caenorhabditis elegans pas-1 gene Proteins 0.000 description 1
- 101100084503 Caenorhabditis elegans pas-3 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 101710167839 Morphogenetic protein Proteins 0.000 description 1
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 108010031318 Vitronectin Proteins 0.000 description 1
- 102100035140 Vitronectin Human genes 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 108010089975 arginyl-glycyl-aspartyl-serine Proteins 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 230000006287 biotinylation Effects 0.000 description 1
- 238000007413 biotinylation Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000002983 circular dichroism Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000000188 dichroism spectroscopy Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005897 peptide coupling reaction Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000002278 reconstructive surgery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000002109 single walled nanotube Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- ATHGHQPFGPMSJY-UHFFFAOYSA-Q spermidine(3+) Chemical compound [NH3+]CCCC[NH2+]CCC[NH3+] ATHGHQPFGPMSJY-UHFFFAOYSA-Q 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229940126577 synthetic vaccine Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/641—Branched, dendritic or hypercomb peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Nanotechnology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52744203P | 2003-12-05 | 2003-12-05 | |
| PCT/US2004/040546 WO2005056576A2 (en) | 2003-12-05 | 2004-12-06 | Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA06006387A true MXPA06006387A (es) | 2006-09-04 |
Family
ID=34676744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA06006387A MXPA06006387A (es) | 2003-12-05 | 2004-12-06 | Peptidos anfifilicos ramificados, compuestos epitopes relacionados y estructuras auto-ensambladas de los mismos. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7452679B2 (enExample) |
| EP (1) | EP1696944A4 (enExample) |
| JP (1) | JP4741510B2 (enExample) |
| KR (1) | KR20070004561A (enExample) |
| CN (1) | CN1905893A (enExample) |
| AU (1) | AU2004297211A1 (enExample) |
| CA (1) | CA2549391A1 (enExample) |
| MX (1) | MXPA06006387A (enExample) |
| WO (1) | WO2005056576A2 (enExample) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10353856B2 (en) | 2011-03-17 | 2019-07-16 | Carefusion 303, Inc. | Scalable communication system |
| US11087873B2 (en) | 2000-05-18 | 2021-08-10 | Carefusion 303, Inc. | Context-aware healthcare notification system |
| AU2002365162A1 (en) | 2001-11-14 | 2003-07-09 | Northwestern University | Self-assembly and mineralization of peptide-amphiphile nanofibers |
| AU2003215280A1 (en) | 2002-02-15 | 2003-09-09 | Northwestern University | Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
| US7534761B1 (en) | 2002-08-21 | 2009-05-19 | North Western University | Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom |
| US7554021B2 (en) | 2002-11-12 | 2009-06-30 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
| WO2004046167A2 (en) | 2002-11-14 | 2004-06-03 | Northwestern University | Synthesis and self-assembly of abc triblock bola peptide |
| US7390526B2 (en) | 2003-02-11 | 2008-06-24 | Northwestern University | Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon |
| EP1696945B1 (en) | 2003-12-05 | 2012-01-18 | Northwestern University | Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| AU2004297211A1 (en) | 2003-12-05 | 2005-06-23 | Northwestern University | Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| US7923109B2 (en) | 2004-01-05 | 2011-04-12 | Board Of Regents, The University Of Texas System | Inorganic nanowires |
| MX2007008826A (es) * | 2005-01-21 | 2007-11-15 | Univ Northwestern | Metodos y composiciones para encapsulacion de celulas. |
| US7851445B2 (en) | 2005-03-04 | 2010-12-14 | Northwestern University | Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembled compositions and related methods of use |
| US20070154946A1 (en) * | 2005-12-29 | 2007-07-05 | Rajasekaran John J | Massively parallel synthesis of biopolymeric arrays |
| US8834840B1 (en) | 2006-10-04 | 2014-09-16 | Northwestern University | Magnetic resonance imaging of self-assembled biomaterial scaffolds |
| US7622295B2 (en) * | 2006-12-19 | 2009-11-24 | Edelmira Cabezas | Molecular microarrays and helical peptides |
| WO2008101104A2 (en) | 2007-02-14 | 2008-08-21 | Northwestern University | Aligned nanofibers and related methods of use |
| US8076295B2 (en) | 2007-04-17 | 2011-12-13 | Nanotope, Inc. | Peptide amphiphiles having improved solubility and methods of using same |
| WO2009026233A2 (en) * | 2007-08-17 | 2009-02-26 | Northwestern University | Self assembling peptide systems and methods |
| US9457056B2 (en) * | 2007-12-04 | 2016-10-04 | Ben-Gurion University Of The Negev Research And Development Authority | Peptides comprising alternating hydrophobic and anionic amino acids for treatment of osteoporosis |
| US8883967B2 (en) | 2009-03-27 | 2014-11-11 | Kansas State University Research Foundation | Branched amphipathic oligo-peptides that self-assemble into vesicles |
| MX2011010780A (es) * | 2009-04-13 | 2011-10-28 | Univ Northwestern | Andamios novedosos basados en peptido para la regeneracion de cartilagos y metodos para su uso. |
| US20100322979A1 (en) * | 2009-06-22 | 2010-12-23 | University Of South Carolina | Peptidomimetic Resorbable Peptide-Polymer Hybrid Polyester Nanoparticles |
| ES2659409T3 (es) * | 2010-03-12 | 2018-03-15 | The Regents Of The University Of California | Conjugados de lípido-péptido-polímero y nanopartículas de los mismos |
| US8546338B2 (en) | 2010-12-08 | 2013-10-01 | Johnson & Johnson Consumer Companies, Inc. | Self-assembling hydrogels based on dicephalic peptide amphiphiles |
| US9949927B2 (en) | 2012-04-10 | 2018-04-24 | The Regents Of The University Of California | Bis-polymer lipid-peptide conjugates and nanoparticles thereof |
| US9169294B2 (en) * | 2013-03-11 | 2015-10-27 | Northwestern University | Anti-angiogenic molecules, nanostructures and uses thereof |
| CA2900564C (en) | 2013-03-13 | 2022-04-26 | Carefusion 303, Inc. | Patient-specific medication management system |
| EP4195119A1 (en) | 2013-03-13 | 2023-06-14 | Carefusion 303 Inc. | Predictive medication safety |
| EP3186272A4 (en) | 2014-08-25 | 2018-02-21 | The Governors Of The University Of Alberta | Functionalized beta-sheet peptide stabilized membrane proteins, constructs comprising same, and methods of forming and using same |
| US20160159869A1 (en) | 2014-12-09 | 2016-06-09 | Northwestern University | Bmp-2-binding peptide amphiphile nanofibers |
| DE102015000363A1 (de) | 2015-01-20 | 2016-07-21 | Emc Microcollections Gmbh | Neue modular funktionalisierbare Peptid-Hydrogele |
| IL282614B2 (en) | 2015-02-06 | 2024-02-01 | Cell Idx Inc | Antigen-conjugated immune reagents |
| US20170051016A1 (en) | 2015-08-17 | 2017-02-23 | Northwestern University | Anti-inflammatory nanofibers |
| WO2017040335A2 (en) | 2015-08-28 | 2017-03-09 | Molecular Transfer, Inc. | Transfection complexes and methods of using the same |
| CN108289926A (zh) | 2015-10-14 | 2018-07-17 | 西北大学 | 用于生长因子递送和骨再生的纳米纤维糊剂 |
| WO2018017604A1 (en) * | 2016-07-18 | 2018-01-25 | Cell Idx, Inc. | Reagent compounds, compositions, kits, and methods for amplified assays |
| US10738294B2 (en) | 2016-09-26 | 2020-08-11 | Northwestern University | Tissue factor (TF)—targeted nanotherapy |
| US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
| WO2018075885A1 (en) | 2016-10-21 | 2018-04-26 | Northwestern University | Anti-microbial supramolecular structures |
| US11174288B2 (en) | 2016-12-06 | 2021-11-16 | Northeastern University | Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria |
| WO2019195741A1 (en) | 2018-04-06 | 2019-10-10 | Northwestern University | Bdnf mimetic peptide amphiphiles |
| US12409205B2 (en) | 2018-04-13 | 2025-09-09 | Northwestern University | Nanomolecules for the treatment of inflammatory bowel diseases |
| WO2019200326A1 (en) | 2018-04-13 | 2019-10-17 | Rarecyte, Inc. | Kits for labeling of biomarkers and methods of using the same |
| US12214076B2 (en) | 2019-02-18 | 2025-02-04 | Northwestern University | Drug delivery vehicles for atherosclerosis nanomedicine |
| CN110917136B (zh) * | 2019-11-25 | 2021-08-24 | 中国人民解放军陆军军医大学 | 一种抗肿瘤的纳米乳佐剂鼻腔粘膜疫苗及其制备方法 |
| US11964000B2 (en) | 2020-04-10 | 2024-04-23 | Northwestern University | Cancer treatment methods using nanofiber stabilized growth factors |
| US12247063B2 (en) | 2020-07-13 | 2025-03-11 | Northwestern University | Cell surface modification by coating with peptide amphiphiles (PAs) |
| US11998589B2 (en) | 2020-07-13 | 2024-06-04 | Northwestern University | PEGylated peptide amphiphile nanofibers and methods of use |
| US12116461B2 (en) | 2020-08-21 | 2024-10-15 | Northwestern University | Host-guest interactions for pa superstructure formation |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) * | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US5130123A (en) * | 1981-03-04 | 1992-07-14 | The University Of Melbourne | Dentifrice |
| US4930077A (en) * | 1987-04-06 | 1990-05-29 | Fan David P | Information processing expert system for text analysis and predicting public opinion based information available to the public |
| US5128319A (en) | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
| JPH0399096A (ja) | 1989-09-11 | 1991-04-24 | Agency Of Ind Science & Technol | 短繊維型螺旋状分子会合体の長さ制御方法 |
| DE4026978A1 (de) * | 1990-08-25 | 1992-02-27 | Bayer Ag | Auf traegern angebrachte ein- oder mehrlagige schichtelemente und ihre herstellung |
| CA2109085C (en) | 1991-04-25 | 2003-03-11 | Keith E. Dionne | Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
| US5580563A (en) * | 1992-05-01 | 1996-12-03 | Tam; James P. | Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof |
| GB9215780D0 (en) * | 1992-07-24 | 1992-09-09 | Univ London Pharmacy | Peptide compounds |
| US5670483A (en) * | 1992-12-28 | 1997-09-23 | Massachusetts Insititute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| US5955343A (en) * | 1992-12-28 | 1999-09-21 | Massachusetts Institute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| US6410690B1 (en) | 1995-06-07 | 2002-06-25 | Medarex, Inc. | Therapeutic compounds comprised of anti-Fc receptor antibodies |
| CA2228118A1 (en) * | 1995-07-28 | 1997-02-13 | Focal, Inc. | Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatments agents |
| FR2739860B1 (fr) | 1995-10-17 | 1998-01-02 | Coletica | Complexes amphiphiles, procede pour leur preparation et compositions en renfermant |
| SE9504347D0 (sv) | 1995-12-01 | 1995-12-01 | Boerje Sellergren | Surface modification technique |
| US6051272A (en) * | 1996-03-15 | 2000-04-18 | The Board Of Trustees Of The University Of Illinois | Method for synthesizing organoapatites on to surgical metal alloys |
| US5733868A (en) * | 1996-04-16 | 1998-03-31 | Depuy Orthopaedics, Inc. | Poly(amino acid) adhesive tissue grafts |
| US6085206A (en) * | 1996-06-20 | 2000-07-04 | Microsoft Corporation | Method and system for verifying accuracy of spelling and grammatical composition of a document |
| US5993541A (en) * | 1996-07-31 | 1999-11-30 | Geo Centers Inc | Process for nucleation of ceramics and product thereof |
| US6096863A (en) * | 1996-08-23 | 2000-08-01 | Regents Of The University Of Minnesota | Self-assembling amphiphiles for construction of peptide secondary structures |
| US6458924B2 (en) | 1996-08-30 | 2002-10-01 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
| BR9806793A (pt) | 1997-01-22 | 2000-05-16 | Univ Texas | Processos e composições de fator tissular para coagulação e tratamento de tumores. |
| US6331406B1 (en) * | 1997-03-31 | 2001-12-18 | The John Hopkins University School Of Medicine | Human enbryonic germ cell and methods of use |
| US6181909B1 (en) * | 1997-07-22 | 2001-01-30 | Educational Testing Service | System and method for computer-based automatic essay scoring |
| US6269368B1 (en) * | 1997-10-17 | 2001-07-31 | Textwise Llc | Information retrieval using dynamic evidence combination |
| DE69841850D1 (de) * | 1997-12-02 | 2010-09-30 | Artecel Sciences Inc | Differenzierung in osteoblasten der fettgewebe-stromalen zellen und ihre verwendungen |
| GB9801061D0 (en) | 1998-01-20 | 1998-03-18 | Univ Nottingham | Patterning technique |
| US6548048B1 (en) | 1998-04-28 | 2003-04-15 | Amersham Health As | Lipopeptide stabilized microbubbles as diagnostic/therapeutic agents |
| DE69936212T2 (de) | 1998-09-04 | 2008-01-24 | Scios Inc., Sunnyvale | Hydrogelzusammensetzungen mit kontrollierter Freigabe für die Verabreichung von Wachstumsfaktoren |
| AU773914B2 (en) | 1999-02-01 | 2004-06-10 | Eidgenossische Technische Hochschule Zurich | Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
| WO2000045831A1 (en) | 1999-02-02 | 2000-08-10 | Thomas Jefferson University | Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans |
| WO2000052145A2 (en) | 1999-03-02 | 2000-09-08 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| US6473730B1 (en) * | 1999-04-12 | 2002-10-29 | The Trustees Of Columbia University In The City Of New York | Method and system for topical segmentation, segment significance and segment function |
| ATE314863T1 (de) | 1999-04-22 | 2006-02-15 | Eidgenoess Tech Hochschule | Kontrollierte abgabe der wachstumsfaktoren von heparin enthaltenden matrizen |
| IL147179A0 (en) | 1999-06-30 | 2002-08-14 | Advanced Cell Tech Inc | Cytoplasmic transfer to de-differentiate recipient cells |
| US6444723B1 (en) * | 1999-11-10 | 2002-09-03 | The United States Of America As Represented By The Secretary Of Commerce | Crosslinked micellar gel composition |
| US6689165B2 (en) | 2000-03-31 | 2004-02-10 | Board Of Supervisors Of Louisana State University And Agricultural And Mechanical College | Surface modifications for enhanced epithelialization |
| JP2003531930A (ja) | 2000-04-28 | 2003-10-28 | ユニバーシティ・カレッジ・ダブリン | 両親媒性大環状誘導体およびそれらの類似体 |
| WO2001086489A2 (en) * | 2000-05-11 | 2001-11-15 | University Of Southern California | Discourse parsing and summarization |
| CA2426692C (en) * | 2000-10-19 | 2011-01-25 | Eidgenossische Technische Hochschule Zurich | Block copolymers for multifunctional self-assembled systems |
| CA2436740A1 (en) * | 2001-01-23 | 2002-08-01 | Educational Testing Service | Methods for automated essay analysis |
| WO2002062969A2 (en) | 2001-02-06 | 2002-08-15 | Massachusetts Institute Of Technology | Cellular reprogramming in peptide hydrogel and uses thereof |
| US7449180B2 (en) | 2001-02-06 | 2008-11-11 | John Kisiday | Macroscopic scaffold containing amphiphilic peptides encapsulating cells |
| WO2003006043A1 (en) * | 2001-07-10 | 2003-01-23 | Massachusetts Institute Of Technology | Surfactant peptide nanostructures, and uses thereof |
| DE20111889U1 (de) | 2001-07-18 | 2001-10-18 | Jack Wolfskin Ausrüstung für Draussen GmbH, 65510 Idstein | Gurt sowie mit einem solchen Gurt ausgestattetes Behältnis |
| AU2002361601A1 (en) | 2001-11-06 | 2003-05-19 | Mark C. Fishman | Stem and progenitor cell capture for tissue regeneration |
| AU2002365162A1 (en) | 2001-11-14 | 2003-07-09 | Northwestern University | Self-assembly and mineralization of peptide-amphiphile nanofibers |
| AU2003215280A1 (en) | 2002-02-15 | 2003-09-09 | Northwestern University | Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
| WO2003084980A2 (en) | 2002-04-02 | 2003-10-16 | Northwestern University | Peptide amphiphile solutions and self assembled peptide nanofiber networks |
| AU2003226428A1 (en) * | 2002-04-18 | 2003-11-03 | Northwestern University | Encapsulation of nanotubes via self-assembled nanostructures |
| AU2003279912A1 (en) * | 2002-06-27 | 2004-01-19 | Northwestern University | Peptide rod amphiphiles and self-assembly of same |
| AU2003285853A1 (en) | 2002-07-23 | 2004-04-30 | Northwestern University | Self-assembled hybrid compositions and method of making, using and ordering same |
| US7534761B1 (en) | 2002-08-21 | 2009-05-19 | North Western University | Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom |
| WO2004106359A2 (en) * | 2002-09-23 | 2004-12-09 | Northwestern University | Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals |
| US7554021B2 (en) * | 2002-11-12 | 2009-06-30 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
| WO2005003292A2 (en) * | 2002-11-12 | 2005-01-13 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
| WO2004046167A2 (en) | 2002-11-14 | 2004-06-03 | Northwestern University | Synthesis and self-assembly of abc triblock bola peptide |
| US7390526B2 (en) * | 2003-02-11 | 2008-06-24 | Northwestern University | Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon |
| EP1696945B1 (en) | 2003-12-05 | 2012-01-18 | Northwestern University | Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| AU2004297211A1 (en) | 2003-12-05 | 2005-06-23 | Northwestern University | Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| US20050214257A1 (en) | 2003-12-23 | 2005-09-29 | Northwestern University | Compositions and methods for controlling stem cell and tumor cell differentiation, growth, and formation |
| MX2007008826A (es) * | 2005-01-21 | 2007-11-15 | Univ Northwestern | Metodos y composiciones para encapsulacion de celulas. |
| US7851445B2 (en) | 2005-03-04 | 2010-12-14 | Northwestern University | Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembled compositions and related methods of use |
-
2004
- 2004-12-06 AU AU2004297211A patent/AU2004297211A1/en not_active Abandoned
- 2004-12-06 JP JP2006542793A patent/JP4741510B2/ja not_active Expired - Fee Related
- 2004-12-06 MX MXPA06006387A patent/MXPA06006387A/es not_active Application Discontinuation
- 2004-12-06 US US11/005,314 patent/US7452679B2/en not_active Expired - Fee Related
- 2004-12-06 KR KR1020067013465A patent/KR20070004561A/ko not_active Withdrawn
- 2004-12-06 CA CA002549391A patent/CA2549391A1/en not_active Abandoned
- 2004-12-06 EP EP04817012A patent/EP1696944A4/en not_active Withdrawn
- 2004-12-06 WO PCT/US2004/040546 patent/WO2005056576A2/en not_active Ceased
- 2004-12-06 CN CNA2004800406518A patent/CN1905893A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1905893A (zh) | 2007-01-31 |
| AU2004297211A1 (en) | 2005-06-23 |
| JP2007535493A (ja) | 2007-12-06 |
| US20050208589A1 (en) | 2005-09-22 |
| EP1696944A2 (en) | 2006-09-06 |
| KR20070004561A (ko) | 2007-01-09 |
| WO2005056576A3 (en) | 2006-01-19 |
| WO2005056576A2 (en) | 2005-06-23 |
| US7452679B2 (en) | 2008-11-18 |
| EP1696944A4 (en) | 2008-11-05 |
| CA2549391A1 (en) | 2005-06-23 |
| JP4741510B2 (ja) | 2011-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7452679B2 (en) | Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof | |
| Hamley | Self-assembly of amphiphilic peptides | |
| Raymond et al. | Multicomponent peptide assemblies | |
| Cavalli et al. | Amphiphilic peptides and their cross-disciplinary role as building blocks for nanoscience | |
| US8748569B2 (en) | Peptide amphiphiles and methods to electrostatically control bioactivity of the ikvav peptide epitope | |
| Mendes et al. | Self‐assembly in nature: using the principles of nature to create complex nanobiomaterials | |
| Edwards-Gayle et al. | Self-assembly of bioactive peptides, peptide conjugates, and peptide mimetic materials | |
| Jung et al. | Co-assembling peptides as defined matrices for endothelial cells | |
| US8076295B2 (en) | Peptide amphiphiles having improved solubility and methods of using same | |
| US20150218252A1 (en) | Self-assembling peptides, peptide nanostructures and uses thereof | |
| US20050272662A1 (en) | Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals | |
| MXPA06006388A (es) | Peptidos anfifilicos de auto-ensamble y metodos relacionados para el suministro del factor de crecimiento. | |
| CN104940949A (zh) | 一种抗肿瘤多肽纳米药物及其制备方法和应用 | |
| WO2004003561A9 (en) | Peptide rod amphiphiles and self-assembly of same | |
| US8575311B2 (en) | Collagen peptide conjugates and uses therefor | |
| Prakash Sharma et al. | Self-assembled peptide nanoarchitectures: applications and future aspects | |
| WO2008008523A1 (en) | COMPOUNDS THAT BIND α5β1 INTEGRIN AND METHODS OF USE | |
| US9238010B2 (en) | Vesicles and nanostructures from recombinant proteins | |
| US12116461B2 (en) | Host-guest interactions for pa superstructure formation | |
| US8834840B1 (en) | Magnetic resonance imaging of self-assembled biomaterial scaffolds | |
| Riegle | Multicomponent Supramolecular Peptide Biomaterials | |
| Cho | Self-Assembling Lipopeptide Nanocarriers for Targeted Cellular Uptake | |
| HK1224959A1 (en) | Implantable meshes for controlling the movement of fluids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |